Basal nitric oxide synthesis in essential hypertension

Lancet

Volumn 349, Issue 9055, 1997, Pages 837-842

  Forte, Pablo ^a   Copland, Mhairi ^b   Smith, Lorna M ^b   Milne, Eric ^c   Sutherland, John ^b   Benjamin, Nigel ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; NITRATE; NITRIC OXIDE; NITROGEN 15;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEASUREMENT; OXIDATION; PRIORITY JOURNAL; SEX DIFFERENCE; SYNTHESIS; URINE LEVEL; VASCULAR ENDOTHELIUM;

EID: 0030991825     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07631-3     Document Type: Article

References (30)

1. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; ii: 997-1000.
2. G-mono-methyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertension 1992; 10: 1025-31.
3. G-mono-methyl-L-arginine of vasodilator effects of acetycholine and methacholine in human forearm vasculature. Br J Pharmacol 1993; 110: 736-38.
4. Duff F, Greenfield ADM, Shepherd JT, Thompson ID. A quantitative study of the response to acetylcholine and histamine of the blood vessels of the human hand and forearm. J Physiol (Lond) 1953; 120: 160-70.
5. Cockroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036-40.
6. Hirata Y, Tomita M, Takada S, Yoshimi H. Vascular receptor binding activities and cyclic GMP responses by synthetic human and rat atrial natriuretic peptides (ANP) and receptor down-regulation by ANP. Biochem Biophys Res Commun 1985; 128 (2): 538-46.
7. Archer S. Measurement of nitric oxide in biological fluids. FASEB J 1993; 7: 349-60.
8. Hibbs JB, Wetenfelder C, Taintor R, et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992; 89: 867-77.
9. 15N]nitrate in biological fluids. Anal Chem 1982; 126: 131-38.
10. Westfelt UN, Benthin G, Lundin S, Stenqvist O, Wennmalm Ä. Conversion of inhaled nitric oxide to nitrate in man. Br J Pharmacol 1995; 114: 1621-24.
11. 15N analysis. Soil Sci Soc Am Proc 1989; 53: 1707-11.
12. Hauck RD, Melsted SW, Yankwich PE. Use of N-isotope distribution in nitrogen gas in the study of dinitrification. Soil Sci 1958; 86: 287-91.
13. Gibaldi M, Perrier D. Pharmacokinetics: drugs and the pharmaceutical sciences, vol 1, 2nd edn. New York: Marcel Dekker, 1982.
14. Vallance P, Patton S, Bhagat K, et al. Direct measurement of nitric oxide in human beings. Lancet 1995; 345: 153-54.
15. Wennmalm A, Benthin G, Edlund A, et al. Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ Res 1993; 73: 1121-27.
16. National Academy of Sciences Committee on Nitrate and Alternative C uring Agents in Food. The health effects of nitrate, nitrite and N-nitroso compounds. Washington DC: National Academy Press, 1981.
17. Winquist RJ, Bating PB, Baskin EP, Wallace AA. Decreased endothelium-dependent relaxation in New Zealand genetic hypertensive rats. J Hypertension 1984; 2: 541-45.
18. Schilling J, Holzer P, Guggenbach M, et al. Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. Europ Respir J 1994; 7: 467-71.
19. Marietta MA, Yoon PS, Iyengar R, Leaf CD, Wishnock JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706-11.
20. Tesch JW, Rehg WR, Sievers RE. Microdetermination of nitrates and nitrites in saliva, blood, water, and suspended particulates in air by gas chromatography. J Chromatogr 1976; 126: 743-45.
21. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Induction of constitutive nitric oxide synthase by estradiol in human endothelial cells. Hypertension 1994; 24: 386 (abstr).
22. Chowienczyk PJ, Cockcroft JR, Brett S, Ritter JM. Evidence for increased nitric oxide synthesis in forearm resistance vessels of premenopausal women. J Hypertension 1994; 12: 1322 (abstr).
23. Jilma B, Kastner J, Mensik C, et al. Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci 1996; 58: 469-76.
24. Takahashi H, Nakanishi T, Nishimura M, Tanaka H, Yoshimura M. Measurements of serum levels of nitrate ions in men and women: implications of endothelial-derived relaxing factor in blood pressure regulation and atherosclerosis. J Cardiovasc Pharmacol 1992; 20 (suppl 12): S214-16.
25. Jüngersten L, Edlund A, Petersson A-S, Wennmalm Ä. Plasma nitrate as an index of endogenous nitric oxide formation in man: analysis of kinetics, confounding factors, and response to immunological challenge. Clin Physiol 1996; 16: 369-79.
26. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20 (suppl 12): S60-62.
27. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 6: 1298-303.
28. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993; 21: 1145-51.
29. Creager MA, Roddy MA, Coleman SM, Dzau VJ. The effect of ACE inhibition on endothelium-dependent vasodilatation in hypertension. J Vasc Res 1992; 29: 97 (abstr).
30. Lyons D, Webster J, Benjamin N. The effect of antihypertensive therapy on local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension. J Hypertension 1994; 12: 1047-52.